title: Reply to: methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.
authors.affiliation: Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Israel. icohen@tau.ac.il.
authors.forename: Ian J
authors.identifier: http://orcid.org/0000-0002-5364-3275
authors.initials: IJ
authors.lastname: Cohen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002551:Cerebral Ventricle Neoplasms / Q000188:drug therapy*; D004806:Ependymoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage*; D018335:Rhabdoid Tumor / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D008727:Methotrexate